C4 Therapeutics
MA - WatertownBiotechnology
Focus: C4 Therapeutics is a clinical-stage biotechnology company focused on ubiquitin-proteasome system (UPS) and protein degradation therapeutics in oncology. The company is headquartered in Watertown, MA and operates as a pre-revenue biotech with an early-stage pipeline.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Open Jobs
4
Should You Work at C4 Therapeutics?
AI assessmentStrong fit for mission-driven scientists and operators willing to accept early-stage risk for meaningful scientific contribution and upside potential in a differentiated technology platform.
Why Work Here
- Ground-floor opportunity in a novel modality (protein degradation) with growing industry validation and competitive differentiation
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
cemsidomide
Multiple MyelomaClinical Trials (1)
NCT04756726Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Phase 1Help build intelligence for C4 Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.